Diabetic Macular Edema Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ALIM | B | Alimera Sciences, Inc. | 0.00 | |
RZLT | B | Rezolute, Inc. | -0.95 | |
KALV | C | KalVista Pharmaceuticals, Inc. | 1.82 | |
OCS | D | Oculis Holding AG | 0.21 | |
OCUP | F | Ocuphire Pharma, Inc. | 1.94 | |
EYPT | F | EyePoint Pharmaceuticals, Inc. | 7.62 | |
OPT | F | Opthea Limited | -0.84 | |
AMPE | F | Ampio Pharmaceuticals, Inc. | 0.00 | |
EPRX | F | Eupraxia Pharmaceuticals Inc. | -0.79 |
Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
XPH | D | SPDR S&P Pharmaceuticals ETF | 0.83 | |
PILL | F | Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF | 0.69 | |
VFMO | A | Vanguard U.S. Momentum Factor ETF | 0.24 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.23 | |
IWC | C | iShares Microcap ETF | 0.22 |
Compare ETFs
- Diabetic Macular Edema
Diabetic retinopathy, also known as diabetic eye disease, is a medical condition in which damage occurs to the retina due to diabetes mellitus. It is a leading cause of blindness.Diabetic retinopathy affects up to 80 percent of those who have had diabetes for 20 years or more. At least 90% of new cases could be reduced with proper treatment and monitoring of the eyes. The longer a person has diabetes, the higher his or her chances of developing diabetic retinopathy. Each year in the United States, diabetic retinopathy accounts for 12% of all new cases of blindness. It is also the leading cause of blindness in people aged 20 to 64.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles